Investors must take note of Surgery Partners Inc’s (SGRY) performance last week, which was -0.10%.

Surgery Partners Inc (NASDAQ: SGRY) kicked off on Tuesday, down -0.43% from the previous trading day, before settling in for the closing price of $21.10. Over the past 52 weeks, SGRY has traded in a range of $19.50-$35.29.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 9.35% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -15.54%. With a float of $73.96 million, this company’s outstanding shares have now reached $127.13 million.

In an organization with 13500 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 21.47%, operating margin of 12.58%, and the pretax margin is 4.21%.

Surgery Partners Inc (SGRY) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Surgery Partners Inc is 41.82%, while institutional ownership is 68.04%. The most recent insider transaction that took place on Sep 05 ’24, was worth 283,652. Before that another transaction happened on Sep 04 ’24, when Company’s National Group President sold 6,325 for $31.11, making the entire transaction worth $196,742. This insider now owns 48,236 shares in total.

Surgery Partners Inc (SGRY) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -15.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 46.10% during the next five years compared to 54.69% growth over the previous five years of trading.

Surgery Partners Inc (NASDAQ: SGRY) Trading Performance Indicators

Take a look at Surgery Partners Inc’s (SGRY) current performance indicators. Last quarter, stock had a quick ratio of 1.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.89. Likewise, its price to free cash flow for the trailing twelve months is 16.34.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit 0.37 in the next quarter and is forecasted to reach 0.95 in one year’s time.

Technical Analysis of Surgery Partners Inc (SGRY)

Let’s dig in a bit further. During the last 5-days, its volume was 1.06 million. That was better than the volume of 1.0 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.55%. Additionally, its Average True Range was 1.17.

During the past 100 days, Surgery Partners Inc’s (SGRY) raw stochastic average was set at 10.44%, which indicates a significant decrease from 47.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.19% in the past 14 days, which was higher than the 54.82% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $25.73, while its 200-day Moving Average is $27.37. However, in the short run, Surgery Partners Inc’s stock first resistance to watch stands at $21.32. Second resistance stands at $21.64. The third major resistance level sits at $21.86. If the price goes on to break the first support level at $20.78, it is likely to go to the next support level at $20.56. The third support level lies at $20.24 if the price breaches the second support level.

Surgery Partners Inc (NASDAQ: SGRY) Key Stats

The company with the Market Capitalisation of 2.67 billion has total of 127,114K Shares Outstanding. Its annual sales at the moment are 2,743 M in contrast with the sum of -11,900 K annual income. Company’s last quarter sales were recorded 770,400 K and last quarter income was -31,700 K.